JB
CATX icon

Julian Baker’s Perspective Therapeutics CATX Stock Holding History

Julian Baker’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,979
Closed -$178K – 97
2024
Q1 		$178K Sell
14,979
-748,991
-98% -$6.39M ﹤0.01% 85
2023
Q4 		$3.07M Hold
763,970
– – 0.03% 66
2023
Q3 		$2.09M Buy
763,970
+532,041
+229% +$2.48M 0.01% 85
2023
Q2 		$1.55M Buy
+231,929
New +$1.41M 0.01% 99

Other funds holding CATX

CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Julian Baker's CATX Position: Q2 2024 in Review

Julian Baker sold out of Perspective Therapeutics (CATX) in Q2 2024, closing a stake of 14,979 shares — an estimated $178K sold.

Julian Baker first reported a position in CATX in Q2 2023 and held it in 4 quarters. The position peaked at $3.07M in Q4 2023. 105 funds tracked by Wall St. Rank hold CATX as of Q2 2024.

  • Julian Baker reported no remaining Perspective Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Julian Baker sold 14,979 Perspective Therapeutics shares in Q2 2024, an estimated $178K.
  • Julian Baker first reported a position in Perspective Therapeutics in Q2 2023 and held it in 4 quarters.
  • Julian Baker's Perspective Therapeutics position peaked at $3.07M in Q4 2023.
  • 105 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2024.

Based on Baker Bros. Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.